CLINICAL_TRIALS
ClinicalTrials.gov record update
Phase I/II Study of Autologous (Central Memory/Naïve) CD8+ T Cells That Have Been Transduced to Express a WT1-Specific T Cell Receptor for Treatment of AML
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT02770820
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:38:26.207336+00:00
- Published At
- 2021-06-23T00:00:00+00:00
- Record Updated At
- 2021-10-29
- Results Posted At
- 2021-06-23
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Acute Myeloid Leukemia", "EBV-Positive Neoplastic Cells Present", "HLA-A*0201 Positive Cells Present", "Blasts Under 5 Percent of Bone Marrow Nucleated Cells", "Elevated WT1"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2021-10-29"- protocolSection.identificationModule.nctId
"NCT02770820"- protocolSection.identificationModule.officialTitle
"Phase I/II Study of Autologous (Central Memory/Na\u00efve) CD8+ T Cells That Have Been Transduced to Express a WT1-Specific T Cell Receptor for Treatment of AML"- protocolSection.statusModule.overallStatus
"TERMINATED"- protocolSection.designModule.phases
["PHASE1", "PHASE2"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
"2021-06-23"
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.